home  
     
Slide 149 Interventions for Tuberculosis Control and Elimination
next Next
previous Previous
beginning First
last Last

largely based on the re-analysis of the Alaska studies, the American Thoracic Society and the United States Centers for Disease Control and Prevention changed their recommendations for preventive therapy in 2003. For isoniazid, the nine-month regimen is now the recommended standard. The six-month regimen is explicitly discouraged for patints with HIV infection, with fibrotic lesions, or for children, thus the perhaps three most important indications for preventive therapy.

If rifampicin is used, a 4-month regimen of rifampicin alone is recommended.

   
Go to top

Last update: September 29, 2010